drugset / Trial / NCT05220072
Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156
NaSingle-groupOpen-labelTreatment
Summary
The study is designed to determine the absorption, distribution, metabolism and elimination (ADME) of BIA 28-6156 in humans, further explore the PK of BIA 28-6156, evaluate the extent of distribution of total radioactivity into blood cells, provide additional safety and tolerability information and collect samples for metabolite profiling and structural identification.
Timeline
- Start
- 2021-08-28
- Primary completion
- 2021-10-16
- Completion
- 2021-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIA 28-6156 | Unknown | 3.7 mbq | Oral |
| Subject | BIA 28-6156 | Unknown | 60 mg | Oral |